These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 19731939)
1. Synthesis and evaluation of 3-(dihydroxyboryl)benzoic acids as D,D-carboxypeptidase R39 inhibitors. Inglis SR; Zervosen A; Woon EC; Gerards T; Teller N; Fischer DS; Luxen A; Schofield CJ J Med Chem; 2009 Oct; 52(19):6097-106. PubMed ID: 19731939 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of boronic acids as inhibitors of Penicillin Binding Proteins of classes A, B and C. Zervosen A; Bouillez A; Herman A; Amoroso A; Joris B; Sauvage E; Charlier P; Luxen A Bioorg Med Chem; 2012 Jun; 20(12):3915-24. PubMed ID: 22579615 [TBL] [Abstract][Full Text] [Related]
3. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase. Weston GS; Blázquez J; Baquero F; Shoichet BK J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697 [TBL] [Abstract][Full Text] [Related]
4. Crystal structure of a complex between the Actinomadura R39 DD-peptidase and a peptidoglycan-mimetic boronate inhibitor: interpretation of a transition state analogue in terms of catalytic mechanism. Dzhekieva L; Rocaboy M; Kerff F; Charlier P; Sauvage E; Pratt RF Biochemistry; 2010 Aug; 49(30):6411-9. PubMed ID: 20608745 [TBL] [Abstract][Full Text] [Related]
5. Potential transition state analogue inhibitors for the penicillin-binding proteins. Pechenov A; Stefanova ME; Nicholas RA; Peddi S; Gutheil WG Biochemistry; 2003 Jan; 42(2):579-88. PubMed ID: 12525187 [TBL] [Abstract][Full Text] [Related]
6. A boronic-acid-based probe for fluorescence polarization assays with penicillin binding proteins and β-lactamases. Inglis SR; Strieker M; Rydzik AM; Dessen A; Schofield CJ Anal Biochem; 2012 Jan; 420(1):41-7. PubMed ID: 21925482 [TBL] [Abstract][Full Text] [Related]
7. Neisseria gonorrhoeae penicillin-binding protein 3 exhibits exceptionally high carboxypeptidase and beta-lactam binding activities. Stefanova ME; Tomberg J; Olesky M; Höltje JV; Gutheil WG; Nicholas RA Biochemistry; 2003 Dec; 42(49):14614-25. PubMed ID: 14661974 [TBL] [Abstract][Full Text] [Related]
8. Aza-boronic acids as non-beta-lactam inhibitors of AmpC-beta-lactamase. Buzzoni V; Blazquez J; Ferrari S; Calò S; Venturelli A; Costi MP Bioorg Med Chem Lett; 2004 Aug; 14(15):3979-83. PubMed ID: 15225711 [TBL] [Abstract][Full Text] [Related]
9. 4,7-Dichloro benzothien-2-yl sulfonylaminomethyl boronic acid: first boronic acid-derived beta-lactamase inhibitor with class A, C, and D activity. Tan Q; Ogawa AM; Painter RE; Park YW; Young K; DiNinno FP Bioorg Med Chem Lett; 2010 Apr; 20(8):2622-4. PubMed ID: 20299220 [TBL] [Abstract][Full Text] [Related]
10. Unexpected tricovalent binding mode of boronic acids within the active site of a penicillin-binding protein. Zervosen A; Herman R; Kerff F; Herman A; Bouillez A; Prati F; Pratt RF; Frère JM; Joris B; Luxen A; Charlier P; Sauvage E J Am Chem Soc; 2011 Jul; 133(28):10839-48. PubMed ID: 21574608 [TBL] [Abstract][Full Text] [Related]
11. Conformational analysis of bacterial cell wall peptides indicates how particular conformations have influenced the evolution of penicillin-binding proteins, beta-lactam antibiotics and antibiotic resistance mechanisms. Grail BM; Payne JW J Mol Recognit; 2002; 15(3):113-25. PubMed ID: 12203837 [TBL] [Abstract][Full Text] [Related]
12. Toward better antibiotics: crystallographic studies of a novel class of DD-peptidase/beta-lactamase inhibitors. Silvaggi NR; Kaur K; Adediran SA; Pratt RF; Kelly JA Biochemistry; 2004 Jun; 43(22):7046-53. PubMed ID: 15170342 [TBL] [Abstract][Full Text] [Related]
13. Basic design of beta-lactam antibiotics: penams and analogues and monocyclic beta-lactams. Ekström B Scand J Infect Dis Suppl; 1984; 42():38-49. PubMed ID: 6335599 [TBL] [Abstract][Full Text] [Related]
14. Interaction between non-classical beta-lactam compounds and the Zn2+-containing G and serine R61 and R39 D-alanyl-D-alanine peptidases. Kelly JA; Frère JM; Klein D; Ghuysen JM Biochem J; 1981 Oct; 199(1):129-36. PubMed ID: 6279094 [TBL] [Abstract][Full Text] [Related]
15. Nanomolar inhibitors of AmpC beta-lactamase. Morandi F; Caselli E; Morandi S; Focia PJ; Blázquez J; Shoichet BK; Prati F J Am Chem Soc; 2003 Jan; 125(3):685-95. PubMed ID: 12526668 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of bacterial DD-peptidases (penicillin-binding proteins) in membranes and in vivo by peptidoglycan-mimetic boronic acids. Dzhekieva L; Kumar I; Pratt RF Biochemistry; 2012 Apr; 51(13):2804-11. PubMed ID: 22443299 [TBL] [Abstract][Full Text] [Related]
17. The beta-lactam-sensitive D,D-carboxypeptidase activity of Pbp4 controls the L,D and D,D transpeptidation pathways in Corynebacterium jeikeium. Lavollay M; Arthur M; Fourgeaud M; Dubost L; Marie A; Riegel P; Gutmann L; Mainardi JL Mol Microbiol; 2009 Nov; 74(3):650-61. PubMed ID: 19807868 [TBL] [Abstract][Full Text] [Related]
18. Shifting of the penicillin binding proteins that are the target for inhibition by beta-lactams as a likely mechanism of resistance to antibiotics during therapy. Satta G; Canepari P; Maurici R; Pompei R; Marcialis MA Chemioterapia; 1985 Feb; 4(1):113-5. PubMed ID: 3986940 [TBL] [Abstract][Full Text] [Related]
19. Practical use of DD-peptidase 64-575 for the assay of inhibition activity of natural and synthetic beta-lactam compounds. Solecka J; Lysek R; Furman B; Chmielewski M; Kurzatkowski W Acta Pol Pharm; 2003; 60(2):115-8. PubMed ID: 13678318 [TBL] [Abstract][Full Text] [Related]
20. A mechanism-based inhibitor targeting the DD-transpeptidase activity of bacterial penicillin-binding proteins. Lee M; Hesek D; Suvorov M; Lee W; Vakulenko S; Mobashery S J Am Chem Soc; 2003 Dec; 125(52):16322-6. PubMed ID: 14692773 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]